Allergy Associates, P.A.
Allergy Associates, P.A. was paid $26.61M by Medicaid between Jan 2018 and Dec 2024, across 22 billing codes. Its largest line is 95165, Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials — 37% of everything it billed.
33Billing provider infoALLERGY ASSOCIATES, P.A.
KNOXVILLE, TN 37909
KNOXVILLE, TN 37909
33aNPI1073508347assigned 09/13/2005
33bProvider typeSpecialist
28Total paid$26.61M
24GClaims691,782
24DCodes billed22
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Tennessee
Rank by total paid#1 of 252
Median peer was paid$57K
This provider vs. median467×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 88,579 | $3.02M | |
| 2019 | 94,439 | $3.79M | |
| 2020 | 86,596 | $2.84M | |
| 2021 | 94,773 | $3.86M | |
| 2022 | 108,500 | $4.43M | |
| 2023 | 120,433 | $5.05M | |
| 2024incomplete | 98,462 | $3.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 37% | 46,333 | 39,033 | $9.72M |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 20% | 32,510 | 27,895 | $5.20M |
| 95117 | 17% | 437,521 | 160,845 | $4.47M | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.9% | 56,050 | 50,935 | $2.38M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.6% | 11,779 | 10,073 | $1.21M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.8% | 14,210 | 13,050 | $1.00M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.7% | 11,302 | 10,247 | $722K |
| J2357 | Injection, omalizumab, 5 mg | 2.4% | 432 | 299 | $634K |
| 95115 | 1.9% | 59,547 | 21,026 | $514K | |
| 95024 | 1.1% | 6,550 | 5,537 | $304K | |
| 94010 | <1% | 8,153 | 7,194 | $207K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,561 | 2,717 | $66K |
10 more codes
| 70486 | <1% | 524 | $62K | |
| 99243 | <1% | 552 | $48K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,272 | $35K |
| 94060 | <1% | 627 | $24K | |
| 96401 | <1% | 209 | $11K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 16 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 268 | $445.17 |
| 94664 | <1% | 38 | $429.05 | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 35 | $200.40 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 293 | $24.10 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCONNER, REBECCA (AR ADMINISTRATOR)